NAME Dr Elaine Sanij
CANCER TYPE Ovarian
INSTITUTION Peter MacCallum Cancer Centre
GRANT TYPE $100,000
PROJECT TYPE Research
Defining novel therapeutic strategies for relapsed ovarian cancer
High-grade serous ovarian cancer accounts for 70% of ovarian cancer . Despite good initial responses to chemotherapy, recurrence is common and its five-year survival rate of 43% has not improved over the past three decades. This project has the potential to establish a new treatment paradigm for this disease of high therapeutic need.